Intrapartum cardiotocography in pregnancies with and without fetal CHD
- PMID: 35534874
- DOI: 10.1515/jpm-2021-0139
Intrapartum cardiotocography in pregnancies with and without fetal CHD
Abstract
Objectives: Congenital heart defects (CHD) are the most common inherited abnormalities. Intrapartum cardiotocography (CTG) is still considered a "gold standard" during labor. However, there is a lack of evidence regarding the interpretation of intrapartum CTG in fetuses with CHD. Therefore, the study aimed to compare intrapartum CTG in normal fetuses and fetuses with CHD and describe the association between CTG and neonatal outcomes.
Methods: The present study is a retrospective analysis of the CTG of 395 fetuses. There were three study groups: Group 1: 185 pregnancies with a prenatal diagnosis of CHD, Group 2: 132 high-risk pregnancies without CHD, and Group 3: 78 low-risk pregnancies without CHD.
Results: Abnormal CTG was present statistically OR=3.4 (95%CI: 1.61-6.95) more often in Group 1. The rate of the emergency CS was higher in this group OR=3 (95%CI: 1.3-3.1). Fetuses with CHD and abnormal CTG were more often scored ≤7 Apgar, with no difference in acidemia. The multivariate regression model for Group 1 does not show clinical differences between Apgar scores or CTG assessment in neonatal acidemia prediction.
Conclusions: CTG in fetuses with CHD should be interpreted individually according to the type of CHD and conduction abnormalities. Observed abnormalities in CTG are associated with the fetal heart defect itself. Preterm delivery and rapid cesarean delivery lead to a higher rate of neonatal complications. Health practitioners should consider this fact during decision-making regarding delivery in cases complicated with fetal cardiac problems.
Keywords: congenital heart defects (CHD); congenital heart disease; fetal cardiac malformation; fetal heart rate (FHR); fetal heart tracing; intrapartum; intrapartum cardiotocography (CTG).
© 2022 Walter de Gruyter GmbH, Berlin/Boston.
Similar articles
-
Intrapartum fetal heart rate monitoring in cases of congenital heart disease.Am J Obstet Gynecol. 2009 Jul;201(1):64.e1-6. doi: 10.1016/j.ajog.2009.03.015. Epub 2009 May 30. Am J Obstet Gynecol. 2009. PMID: 19481721
-
Physiological CTG interpretation: the significance of baseline fetal heart rate changes after the onset of decelerations and associated perinatal outcomes.J Matern Fetal Neonatal Med. 2021 Jul;34(14):2349-2354. doi: 10.1080/14767058.2019.1666819. Epub 2019 Sep 18. J Matern Fetal Neonatal Med. 2021. PMID: 31533502
-
Hazard and cumulative incidence of umbilical cord metabolic acidemia at birth in fetuses experiencing the second stage of labor and pathologic intrapartum fetal heart rate requiring expedited delivery.Arch Gynecol Obstet. 2023 Apr;307(4):1225-1232. doi: 10.1007/s00404-022-06594-1. Epub 2022 May 21. Arch Gynecol Obstet. 2023. PMID: 35596749 Free PMC article.
-
Characteristics of Heart Rate Tracings in Preterm Fetus.Medicina (Kaunas). 2021 May 25;57(6):528. doi: 10.3390/medicina57060528. Medicina (Kaunas). 2021. PMID: 34070249 Free PMC article. Review.
-
Machine learning on cardiotocography data to classify fetal outcomes: A scoping review.Comput Biol Med. 2024 Apr;172:108220. doi: 10.1016/j.compbiomed.2024.108220. Epub 2024 Mar 7. Comput Biol Med. 2024. PMID: 38489990
Cited by
-
The Management of Pregnancy Complicated with the Previable Preterm and Preterm Premature Rupture of the Membranes: What about a Limit of Neonatal Viability?-A Review.Diagnostics (Basel). 2022 Aug 22;12(8):2025. doi: 10.3390/diagnostics12082025. Diagnostics (Basel). 2022. PMID: 36010375 Free PMC article. Review.
-
Impact of combined propranolol and oxytocin on the process and outcomes of labor: a meta-analysis of randomized controlled trials.Eur J Clin Pharmacol. 2024 Jun;80(6):901-910. doi: 10.1007/s00228-024-03659-9. Epub 2024 Mar 4. Eur J Clin Pharmacol. 2024. PMID: 38436704
-
Current Innovative Methods of Fetal pH Monitoring-A Brief Review.Diagnostics (Basel). 2022 Nov 3;12(11):2675. doi: 10.3390/diagnostics12112675. Diagnostics (Basel). 2022. PMID: 36359522 Free PMC article. Review.
References
-
- Hamela Olkowska, A, Szymkiewicz Dangel, J, Romejko Wolniewicz, E. Cardiotocography in fetal heart arrhythmia – analysis of cases. Ginekol Pol 2010;81:622–8.
-
- Yagel, S, Weissman, A, Rotstein, Z, Manor, M, Hegesh, J, Anteby, E, et al.. Congenital heart defects: natural course and in utero development. Circulation 1997;96:550–5. https://doi.org/10.1161/01.cir.96.2.550.
-
- Hoffman, JIE. Incidence of congenital heart disease: II. Prenatal incidence. Pediatr Cardiol 1995;16:155–65. https://doi.org/10.1007/BF00794186.
-
- Nicolaides, K, Shawwa, L, Brizot, M, Snijders, R. Ultrasonographically detectable markers of fetal chromosomal defects. Ultrasound Obstet Gynecol 1993;3:56–69. https://doi.org/10.1046/j.1469-0705.1993.03010056.x.
-
- Stoll, C. Distribution of single organ malformations in European populations. Ann Genet 1995;38:32–43.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical